ICICI Prudential US Bluechip Equity Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 06-12-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Direct Plan - Growth 83.44 4.51 22.09 12.37 16.28 16.51
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 4.79 1.56 14.21 7.27 11.07 7.76

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Direct Plan - Growth Jan 02, 2013 22.09 12.37 16.28 1.12 2,554.44
Nippon India US Equity Opportunites Fund- Direct Plan- Growth Plan- Growth Option Jul 23, 2015 25.20 9.20 14.70 1.31 562.69
Nippon India Japan Equity Fund- Direct Plan- Growth Plan- Growth Option Aug 26, 2014 16.37 2.19 7.39 1.25 269.03
Franklin Asian Equity Fund - Direct - Growth Jan 01, 2013 -5.61 -6.98 4.58 1.47 249.68
Aditya Birla Sun Life International Equity Fund - Growth - Direct Plan Jan 01, 2013 1.36 5.38 9.13 1.84 182.92

Fund Holdings as on 31-October-2023

  • Gilead Sciences Inc.

  • Walt Disney

  • Charles Schwab Corp

  • Veeva Systems Inc

  • Tyler Technologies Inc

  • 3M Co

  • ECOLAB INC

  • Nike Inc

  • Salesforce.Com Inc

  • Alphabet Inc

  • Intercontinental Exchange

  • Zimmer Biomet Holdings Inc

  • Comcast Corporation

  • Wells Fargo & Co

  • Masco Corp.

  • US Bancorp Inc

  • Medtronic Plc

  • MarketAxess Holdings Inc

  • International Flavors & Fragrances Inc

  • Allegion plc

  • Corteva Inc

  • Equifax Inc.

  • Biogen Inc

  • Pfizer Inc

  • Agilent Technologies Co Ltd

  • Kellogg Co.

  • ETSY INC

  • Polaris Industries Inc.

  • TERADYNE INC

  • Estee Lauder Cos Inc

  • TRANSUNION

  • TREPS

  • Raytheon Technologies Corp

  • Domino's Pizza Inc

  • Amazon com

  • Emerson Electric

  • Fortinet INC

  • Campbell Soup Co

  • Microsoft Corp

  • Bank of New York Mellon (US)

  • Keysight Technologies Inc

  • Honeywell Internation India Pvt Ltd

  • Blackrock (US)

  • Roper Technologies Inc

  • Amgen Inc

  • TRADEWEB MARKETS INC-CLASS A

  • Bank of America Corp

  • Water Corp

  • Microchip Technology Inc.

  • Guidewire Software Inc

  • Berkshire Hathway Inc. (US)

  • Cognizant Tech Solutions

  • Taiwan Semiconductor Mfg. Co. Ltd.

  • Viatris Inc.

  • Wk Kellogg Co

  • Net Current Assets

View More
  • Miscellaneous

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 02-Jan-2013 and currently has an AUM of ₹2,554.44 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹0.12(0.21%)yesterday to ₹58.43.

Among its top 3 holdings the fund has exposure to Gilead Sciences Inc., and

The ICICI Prudential US Bluechip Equity Fund is managed by Rohan Maru and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100